Comparative efficacy and safety of lemborexant 5 mg versus 10 mg for the treatment of insomnia: a systematic review.

Ume Habiba Radeyah Waseem Taha Gul Shaikh Summaiyya Waseem Syed Hassan Ahmed Muhammad Sohaib Asghar

Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2023)

Lemborexant is well integrated with the amelioration of sleep disturbances in insomniac patients, as shown by a decrease in eSOL and sWASO and a rise in sSE, sTST, quality of sleep, and morning alertness. Effects last 12 months after therapy.

Keyphrases

sleep quality
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
physical activity
prognostic factors
stem cells
depressive symptoms
bone marrow
quality improvement
cell therapy